China strengthens its Health Silk Road initiative in Africa, funding HIV/AIDS projects and local medicine manufacturing, while the US's influence through PEPFAR wanes amid declined bilateral agreements over data concerns.
The US is withdrawing all funding for South Africa's HIV/AIDS response via PEPFAR, a program contributing $400m annually. This decision, linked to policy disagreements and concerns over minority treatment, risks undoing years of progress in prevention and support for vulnerable communities.
A recent poll shows 74% of US midterm voters support funding PEPFAR, an HIV/AIDS initiative. Despite bipartisan popularity and a moral argument for its support, the program faces changes under the Trump administration, with concerns about its future and impact on global health systems.
After months of waiting, PEPFAR data was finally released showing 20+ million people on HIV treatment, but HIV experts warn of severe disruptions including 24% loss of frontline healthcare workers and 13-30% drops in new HIV diagnoses in affected areas. Government officials call the numbers successful while advocates describe the situation as a "five-alarm fire."
